Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
New China Life Insurance Company Ltd. (601336.SS)
CNY65.55
+1.04 (+1.61%)
CN SHH Financial Services Insurance - Life
Address
New China Insurance Tower 100022
Beijing, CN
Beijing, CN
CEO
Yucheng Yang
Website
newchinalife.com
IPO
2011-12-16
ISIN CNE1000019Y0
Also trades on
Hong Kong Stock Exchange · 1336.HK (HKD)
Other OTC · NWWCF (USD)
Shanghai Stock Exchange · 601336.SS (CNY)
Description
New China Life Insurance Company Ltd., founded in 1996 and based in Beijing, China, provides a wide array of life insurance products and related services. These offerings are extended to both private citizens and institutional clients throughout the People's Republic of China. The company's operations are divided into three primary divisions: individual policy coverage, collective insurance for groups, and a segment for miscellaneous business activities. Beyond its core insurance business, the firm also delivers asset management, professional development, digital commerce platforms, and healthcare services. Furthermore, it actively invests in, develops, leases, and manages various real estate properties.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY65.55
+1.04 (+1.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
26M
Beta
0.87
Float Shares
894.46M
Free Float %
28.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.91% | +0.25% | +4.75% | -16.76% | -6.07% | -6.37% | +29.46% | +65.13% | +36.13% | +65.76% | +147.01% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
65.55
DCF (Unlevered)
396.12
+504.3%
DCF (Levered)
635.74
+869.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
54% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 7 | 0 |
| Buy | 7 | 0 |
| Hold | 3 | 0 |
| Sell | 7 | 0 |
| Strong Sell | 2 | 0 |
Quality scores
Altman Z-Score
0.36
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
4 / 5
High
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Insurance - Life: +10.6%+4.2% Q1'26: +31.7% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+38.3% ★ Q1'26: +10.1% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+152.8% ★ Q1'26: +111.2% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+32.8% ★ Q1'26: +18.0% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+15.8% ★ Q1'26: +13.9% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×4.68× Q1'26: 4.13× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 12 EPS Ana. |
Dec 2027 5 Rev. Ana. 12 EPS Ana. |
Dec 2028 2 Rev. Ana. 9 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
157.92B
est: 116.35B (+35.7%)
|
146.03B
est: 112.39B (+29.9%)
|
143.81B
est: 110.63B (+30.0%)
|
153.76B
est: 124.78B (+23.2%)
|
174.07B
est: 141.76B (+22.8%)
|
206.28B
est: 163.42B (+26.2%)
|
222.00B
est: 161.41B (+37.5%)
|
106.89B
est: 161.92B (-34.0%)
|
70.10B
est: 52.30B (+34.0%)
|
128.86B
est: 111.22B (+15.9%)
|
134.21B
est: 147.23B (-8.8%)
|
160.42B
149.63B – 182.80B
+9.0% YoY
|
172.75B
152.92B – 223.19B
+7.7% YoY
|
186.89B
169.66B – 227.90B
+8.2% YoY
|
| EBITDA |
12.19B
est: 53.39B (-77.2%)
|
6.95B
est: 51.57B (-86.5%)
|
7.89B
est: 50.76B (-84.4%)
|
11.62B
est: 57.25B (-79.7%)
|
14.48B
est: 65.05B (-77.7%)
|
17.01B
est: 74.98B (-77.3%)
|
17.29B
est: 74.06B (-76.7%)
|
99.86B
est: 74.30B (+34.4%)
|
67.84B
est: 26.71B (+154.0%)
|
29.88B
est: 56.80B (-47.4%)
|
45.84B
est: 75.18B (-39.0%)
|
81.92B
76.41B – 93.35B
+9.0% YoY
|
88.21B
78.09B – 113.97B
+7.7% YoY
|
95.43B
86.63B – 116.38B
+8.2% YoY
|
| EBIT |
11.78B
est: 51.76B (-77.2%)
|
6.48B
est: 49.99B (-87.0%)
|
7.33B
est: 49.21B (-85.1%)
|
10.51B
est: 55.51B (-81.1%)
|
13.22B
est: 63.06B (-79.0%)
|
15.49B
est: 72.69B (-78.7%)
|
15.67B
est: 71.80B (-78.2%)
|
98.07B
est: 72.03B (+36.2%)
|
66.07B
est: 25.91B (+155.0%)
|
28.14B
est: 55.10B (-48.9%)
|
44.04B
est: 72.94B (-39.6%)
|
79.47B
74.13B – 90.56B
+9.0% YoY
|
85.58B
75.76B – 110.57B
+7.7% YoY
|
92.59B
84.05B – 112.91B
+8.2% YoY
|
| Net Income |
8.60B
est: 9.08B (-5.2%)
|
4.94B
est: 5.48B (-9.8%)
|
5.38B
est: 6.27B (-14.2%)
|
7.92B
est: 7.98B (-0.7%)
|
14.56B
est: 13.78B (+5.6%)
|
14.29B
est: 13.37B (+6.9%)
|
14.95B
est: 15.11B (-1.1%)
|
21.50B
est: 7.89B (+172.6%)
|
8.71B
est: 9.82B (-11.3%)
|
26.23B
est: 29.95B (-12.4%)
|
36.28B
est: 36.90B (-1.7%)
|
28.95B
20.48B – 45.55B
-21.6% YoY
|
30.87B
20.77B – 50.21B
+6.6% YoY
|
33.24B
22.67B – 60.75B
+7.7% YoY
|
| SGA |
3.05B
est: 2.22B (+37.4%)
|
2.26B
est: 2.14B (+5.4%)
|
2.33B
est: 2.11B (+10.7%)
|
2.28B
est: 2.38B (-4.3%)
|
2.32B
est: 2.70B (-14.2%)
|
2.44B
est: 3.11B (-21.7%)
|
2.14B
est: 3.08B (-30.5%)
|
1.74B
est: 3.09B (-43.6%)
|
2.37B
est: 873.09M (+171.4%)
|
3.06B
est: 1.86B (+64.9%)
|
—
est: 2.46B (-100.0%)
|
2.68B
2.50B – 3.05B
+9.0% YoY
|
2.88B
2.55B – 3.73B
+7.7% YoY
|
3.12B
2.83B – 3.80B
+8.2% YoY
|
| EPS |
2.76
est: 2.91 (-5.1%)
|
1.58
est: 1.76 (-10.0%)
|
1.73
est: 2.01 (-13.9%)
|
2.54
est: 2.56 (-0.7%)
|
4.67
est: 4.42 (+5.7%)
|
4.58
est: 4.29 (+6.9%)
|
4.79
est: 4.84 (-1.1%)
|
6.89
est: 2.53 (+172.5%)
|
2.79
est: 3.15 (-11.3%)
|
8.41
est: 7.88 (+6.7%)
|
11.63
est: 11.97 (-2.9%)
|
10.41
6.57 – 14.60
-13.0% YoY
|
11.13
6.66 – 16.09
+6.9% YoY
|
12.38
7.27 – 19.47
+11.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 4/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-06 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 4/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
100.01B
OE per share TTM
32.06
Owner's Yield
49.15%
Maintenance CapEx ratio
15.76%
Maint CapEx / Avg PPE
12.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 122 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Matthews China Active ETF MCH | 1.99% | 454.9K | 0.79% |
| 2 | HSBC MSCI China A UCITS ETF HMCT.L | 0.28% | 370.6K | 0.30% |
| 3 | JPMorgan ETFs (Ireland) ICAV - China A Research Enhanced Index Equity Active UCITS ETF JREC.L | 0.27% | 62.1K | 0.40% |
| 4 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.26% | 369.3K | 0.35% |
| 5 | iShares MSCI China A UCITS ETF CNYA.L | 0.26% | 7.95M | 0.40% |
| 6 | iShares MSCI China A UCITS ETF CNYE.MI | 0.26% | 262.3K | 0.45% |
| 7 | iShares MSCI China A ETF CNYA | 0.25% | 587.6K | 0.60% |
| 8 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.24% | 332.7K | 0.35% |
| 9 | Xtrackers Harvest CSI 300 China A-Shares ETF ASHR | 0.21% | 2.83M | 0.65% |
| 10 | Samsung KODEX China CSI300 ETF 283580.KS | 0.20% | 397.2K | 0.12% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.54M
Shares Outstanding
3.12B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yucheng Yang | Executive Chairman | 2M | male |
| Xingfeng Gong | President, Chief Financial Officer & Executive Director | 2M | male |
| Hongbo Qin | Vice President | 2M | male |
| Xigang Wang | Chief Compliance Officer | 2M | male |
| Wenfeng Li | Assistant President | 1M | male |
| Chen Liu | Chief Information Officer | 1M | female |
| Zhiyong Liu | Assistant to the President & Joint Company Secretary | 1M | male |
| Chief Actuary | 1M | male | |
| Tao Zhang | Head of Accounting Department | — | male |
| Zhangmei | Head in charge of Accounting Department | — | female |
| Sau Mei Ng ACIS FCIS | Company Secretary | — | female |
| Zhongzhu Wang | GM of Discipline Inspection & Supervision Office | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 601336.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
